News archive

Tuesday, February 16, 2016

Research contradicting prior findings indicates that benzodiazepines do not increase risk of dementia

A recent study has contradicted previous research regarding the use of benzodiazepines and dementia. Prior research findings have claimed that the use of benzodiazepines, which are drugs commonly used to treat anxiety and insomnia, raises the risk of dementia amongst seniors. However, a study conducted at the School of Pharmacy in the University of Washington aimed to find out whether or not the continued use of these drugs were associated with faster cognitive decline or an increased risk of dementia.

Tuesday, February 16, 2016

Controversial relationship between IGF-1R and Alzheimer's disease resolved

Research from Tel Aviv University has shown promise for a new treatment that may be used for Alzheimer’s disease.

In the brain’s hippocampus, where memories are processed, hyperactivity is associated with Alzheimer’s disease. This study reveals that activity of a particular hormone receptor known as insulin-like growth factor 1 (IGF-1R) and its controversial relation to Alzheimer’s disease is one of the contributors to the hyperactivity in the hippocampus.

Tuesday, February 16, 2016

Cognitive training will not prevent dementia

Recent research has suggested that online brain games and cognitive training do not actually prevent dementia onset or incidence rates. The authors of the study argue that while these activities can train isolated cognitive functions and improve them, cognition is incredibly complex and many forms of dementia cause decline in all areas and functions.

Tuesday, February 9, 2016

Gene found to slow the progression of Alzheimer's disease

A longitudinal study that followed 535 people aged 81 until death showed that the function of a particular gene was associated with the slowing of decline in memory and cognitive ability. This gene, known as brain-derived neurotrophic factor (BDNF), was found in higher levels in the brains of participants who showed slower decline in brain function.

Tuesday, February 9, 2016

Pathological processes of Alzheimer's disease found to be traceable as far as twenty years in advance

Periodically repeated Positron Emission Tomography (PET) scans along with memory tests were used to study families of people with known Alzheimer’s mutations in order to find signs of early onset.

  1. 2018 (61)
    1. May (8)
    2. April (17)
    3. March (12)
    4. February (15)
    5. January (9)
  2. 2017 (141)
    1. December (9)
    2. November (13)
    3. October (13)
    4. September (13)
    5. August (6)
    6. July (15)
    7. June (12)
    8. May (15)
    9. April (12)
    10. March (12)
    11. February (12)
    12. January (9)
  3. 2016 (137)
    1. December (6)
    2. November (10)
    3. October (15)
    4. September (16)
    5. August (12)
    6. July (9)
    7. June (6)
    8. May (15)
    9. April (12)
    10. March (18)
    11. February (9)
    12. January (9)
  4. 2015 (122)
  5. 2014 (174)
  6. 2013 (32)
  7. 2012 (1)